Fardis Maria insider trades
Fardis Maria has filed 6 Form 4s with the SEC that we hold, for CRISPR Therapeutics AG (CRSP) (Director) and Obsidian Therapeutics, Inc. (OBX) (Director). None of these filings reports a purchase (code P) or sale (code S) of common stock; they cover grants, option exercises and other codes. The first filing on our record is dated 2022-06-10 and the latest 2026-08-05.
CRISPR Therapeutics AG (CRSP)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Obsidian Therapeutics, Inc. (OBX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1559231) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms